DexCare, a data-driven intelligence company focused on healthcare access, today announced a $50M Series B funding round led by Transformation Capital, with participation from all existing investors, including Kaiser Permanente, Providence Ventures, Mass General Brigham, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures. In less than one year, DexCare has closed two oversubscribed funding rounds totaling $71 million to-date.
“Hospitals are moving to hybrid care and need a single solution to attract new patients and to connect them both virtually and in-person with their own caregivers,” said Derek Streat, co-founder and CEO of DexCare. “This investment will help us accelerate platform development and go-to-market progress for our growing number of premier health systems such as Kaiser Permanente, Providence, Mass General Brigham, CHS, Houston Methodist and others. Transformation Capital’s digital health focus will help us achieve these goals along with our current line-up of top healthcare-focused partners.” Read more.
